Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, USA; Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, USA.
Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, USA.
Cardiovasc Revasc Med. 2022 Jun;39:28-35. doi: 10.1016/j.carrev.2021.10.012. Epub 2021 Nov 10.
Left ventricular unloading with Impella may improve survival outcomes in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS). However, the optimal timing to initiate left ventricular unloading has yet to be established. Therefore, we conducted a systematic review and meta-analysis to compare survival in patients with AMI-CS who were supported with Impella prior to PCI (pre-PCI) to those in whom support was initiated following PCI (post-PCI).
All studies that evaluated the impact of pre-PCI versus post-PCI Impella placement in patients with AMI-CS were included. Primary endpoints included in-hospital, 30-day, and 6-month survival rates.
We identified five observational studies comparing outcomes in 432 patients with AMI-CS, of which 173 patients were treated with Impella pre-PCI and 259 patients post-PCI. Patients in the pre-PCI group had lower in-hospital mortality compared to patients in the post-PCI group (RR 0.62, 95% CI: 0.50-0.76, I = 0%). The lower mortality rate in the pre-PCI group remained evident at 30 days (HR 0.60, 95% CI: 0.47-0.78, I = 0%) and at 6 months (HR 0.66, 95% CI: 0.44-0.97, I = 0%). There was no difference in the risk of adverse events including reinfarction, stroke, major bleeding, acute ischemic limb, access site bleeding, and hemolysis.
In this meta-analysis of studies evaluating survival among AMI-CS patients with left ventricular unloading initiated pre- versus post-PCI, Impella placement prior to PCI was associated with improved survival.
Impella 辅助左心室卸载可能改善伴心原性休克的急性心肌梗死(AMI-CS)患者的生存结局。然而,启动左心室卸载的最佳时机尚未确定。因此,我们进行了系统评价和荟萃分析,比较了在 PCI 前(PCI 前)和 PCI 后(PCI 后)接受 Impella 支持的 AMI-CS 患者的生存情况。
所有评估 AMI-CS 患者 PCI 前与 PCI 后 Impella 放置对影响的研究均被纳入。主要终点包括住院期间、30 天和 6 个月的生存率。
我们确定了五项比较 432 例 AMI-CS 患者结局的观察性研究,其中 173 例患者接受了 PCI 前 Impella 治疗,259 例患者接受了 PCI 后 Impella 治疗。与 PCI 后组相比,PCI 前组患者住院期间死亡率较低(RR 0.62,95%CI:0.50-0.76,I=0%)。PCI 前组在 30 天(HR 0.60,95%CI:0.47-0.78,I=0%)和 6 个月(HR 0.66,95%CI:0.44-0.97,I=0%)时的死亡率较低仍具有显著意义。不良事件的风险没有差异,包括再梗死、中风、大出血、急性缺血性肢体、入路部位出血和溶血。
在这项比较 AMI-CS 患者左心室卸载的生存情况的研究的荟萃分析中,与 PCI 后相比,PCI 前的 Impella 放置与生存改善相关。